Literature DB >> 23904549

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.

François Maltais, Donald A Mahler, Véronique Pepin, Eric Nadreau, Glenn D Crater, Andrea N Morris, Amanda H Emmett, Thomas J Ferro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23904549     DOI： 10.1183/09031936.00074113

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients.

Authors:  Michael J Berry; Nicholas W Justus; Jordan I Hauser; Ashlee H Case; Christine C Helms; Swati Basu; Zachary Rogers; Marc T Lewis; Gary D Miller
Journal:  Nitric Oxide       Date:  2014-10-27       Impact factor: 4.427

Review 2.  Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.

Authors:  Agnieszka Sliwka; Milosz Jankowski; Iwona Gross-Sondej; Monika Storman; Roman Nowobilski; Malgorzata M Bala
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

Review 3.  Tailoring of corticosteroids in COPD management.

Authors:  Daan A De Coster; Melvyn Jones
Journal:  Curr Respir Care Rep       Date:  2014-07-06

4.  Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.

Authors:  François Maltais; Denis O'Donnell; Juan Bautista Gáldiz Iturri; Anne-Marie Kirsten; Dave Singh; Alan Hamilton; Kay Tetzlaff; Yihua Zhao; Richard Casaburi
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

5.  Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.

Authors:  Yayuan Zheng; Jianhong Zhu; Yuyu Liu; Weiguang Lai; Chunyu Lin; Kaifen Qiu; Junyan Wu; Weimin Yao
Journal:  BMJ       Date:  2018-11-06

6.  Triple therapy for COPD: a crude analysis from a systematic review of the evidence.

Authors:  Jose Luis Lopez-Campos; Laura Carrasco-Hernandez; Esther Quintana-Gallego; Carmen Calero-Acuña; Eduardo Márquez-Martín; Francisco Ortega-Ruiz; Joan B Soriano
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

7.  Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation.

Authors:  Jean Bourbeau; Kim L Lavoie; Maria Sedeno; Dorothy De Sousa; Damijan Erzen; Alan Hamilton; François Maltais; Thierry Troosters; Nancy Leidy
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

Review 8.  The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.

Authors:  Min-Sun Kwak; Eunyoung Kim; Eun Jin Jang; Hyun Jung Kim; Chang-Hoon Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-03

9.  The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Chih-Cheng Lai; Cheng-Hsin Chen; Charlotte Yu Hsuan Lin; Cheng-Yi Wang; Ya-Hui Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.